Skip to main content

New collection: Advances in CAR-T immunotherapy

BMC Biotechnology and BMC Cancer together present the latest collection of articles on the advances in CAR-T immunotherapy covering the entire range of advances from lab to clinic. Click to read more.

BMC Series Focus Issue

July: Inflammation

To celebrate World Allergy Week 2020, the BMC Series is proud to present July’s focus issue dedicated to inflammation. Browse our biology, chemistry and medical titles for insight into recent research in the field, including allergy, autoimmune and inflammatory conditions.

Featured Article

Back to top

           
Lentiviral system for genome editing

In this article the authors demonstrate a new lentivirus-driven method for genome editing of Salmon cells. Read the full article here.

Articles

Aims and scope

BMC Biotechnology is an open access, peer-reviewed journal that considers articles on the manipulation of biological macromolecules or organisms for use in experimental procedures, cellular and tissue engineering or in the pharmaceutical, agricultural biotechnology and allied industries.

The journal welcomes submissions in these broad areas of research:
Applied immunology 
Cellular, tissue and whole organism biotechnology 
Drug discovery and delivery 
Environmental biotechnology 
Food and nutritional biotechnology 
Genetic engineering
Mathematical modeling and statistics in biology
Methods and technological advances in biotechnology 
Microbial biotechnology 
Plant and agricultural biotechnology 
Systems and synthetic biology 

To read the full scope of the journal, click here. 

Read More

BMC Biotechnology is recruiting new Associate Editors

Learn more about the role and requirements here and if interested please complete the accompanying Application form

Read More

Editor


Manuscript Editor


Assistant Editor

  • Lauren McMillan, BioMed Central, UK


Section Editors

  • Joaquim M Cabral, Instituto Superior Tecnico
  • Dennis ClaessenLeiden University
  • Peter J PuntTNO Microbiology & Systems Biology/Leiden University
  • Marko RadicUniversity of Tennessee
  • John J Rossi, Beckman Research Institute City of Hope
  • Igor Stagljar, University of Toronto
  • Hyung Joon Cha, Pohang University of Science and Technology
  • Ting Lu, University of Illinois at Urbana-Champaign

Peter Punt

Peter J. Punt, PhD is Chief Technology Officer of Dutch DNA Biotech BV, a fungal biotechnology technology provider and contract research company situated in the Netherlands. In 2008 he was appointed at Leiden University in the chair of Industrial Biotechnology He joined BMC Biotechnology as a  Section Editor in 2012.

Latest Tweets

2019 Journal Metrics